Structural basis for ligand-dependent dimerization of phenylalanine hydroxylase regulatory domain

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Patel, Dipali ^a,b   Kopec, Jolanta ^a   Fitzpatrick, Fiona ^a,c   Mccorvie, Thomas J ^a   Yue, Wyatt W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; PROTEIN BINDING;

ALLOSTERISM; BINDING SITE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR MODEL; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SMALL ANGLE SCATTERING;

ALLOSTERIC REGULATION; BINDING SITES; HUMANS; LIGANDS; MODELS, MOLECULAR; PHENYLALANINE; PHENYLALANINE HYDROXYLASE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SCATTERING, SMALL ANGLE;

EID: 84962894327     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23748     Document Type: Article

References (49)

1. Konecki, D. S., & Lichter-Konecki, U. The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations. Hum. Genet. 87, 377-388 (1991
2. Wettstein, S., et al. Linking genotypes database with locus-specific database and genotype-phenotype correlation in phenylketonuria. Eur. J. Hum. Genet. 23, 302-309 (2015
3. Fitzpatrick, P. F. Mechanism of aromatic amino acid hydroxylation. Biochemistry. 42, 14083-14091 (2003
4. Grenett, H. E., Ledley, F. D., Reed, L. L., & Woo, S. L. Full-length cDNA for rabbit tryptophan hydroxylase: functional domains and evolution of aromatic amino acid hydroxylases. Proc. Natl. Acad. Sci. USA. 84, 5530-5534 (1987
5. Kobe, B., et al. Structural basis of autoregulation of phenylalanine hydroxylase. Nat. Struct. Biol. 6, 442-448 (1999
6. Fusetti, F., Erlandsen, H., Flatmark, T., & Stevens, R. C. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J. Biol. Chem. 273, 16962-16967 (1998
7. Fitzpatrick, P. F. Allosteric regulation of phenylalanine hydroxylase. Arch. Biochem. Biophys. 519, 194-201 (2012
8. Shiman, R., & Gray, D. W. Substrate activation of phenylalanine hydroxylase A kinetic characterization. J. Biol. Chem. 255, 4793-4800 (1980
9. Doskeland, A. P., Martinez, A., Knappskog, P. M., & Flatmark, T. Phosphorylation of recombinant human phenylalanine hydroxylase: effect on catalytic activity, substrate activation and protection against non-specific cleavage of the fusion protein by restriction protease. Biochem. J. 313 (Pt 2), 409-414 (1996
10. Daubner, S. C., Hillas, P. J., & Fitzpatrick, P. F. Expression and characterization of the catalytic domain of human phenylalanine hydroxylase. Arch. Biochem. Biophys. 348, 295-302 (1997
11. Knappskog, P. M., Flatmark, T., Aarden, J. M., Haavik, J., & Martinez, A. Structure/function relationships in human phenylalanine hydroxylase. Effect of terminal deletions on the oligomerization, activation and cooperativity of substrate binding to the enzyme. Eur. J. Biochem. 242, 813-821 (1996
12. Arturo, E. C., et al. First structure of full-length mammalian phenylalanine hydroxylase reveals the architecture of an autoinhibited tetramer. Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1516967113 (2016
13. Thorolfsson, M., et al. L-phenylalanine binding and domain organization in human phenylalanine hydroxylase: a differential scanning calorimetry study. Biochemistry. 41, 7573-7585 (2002
14. Thorolfsson, M., Teigen, K., & Martinez, A. Activation of phenylalanine hydroxylase: effect of substitutions at Arg68 and Cys237. Biochemistry. 42, 3419-3428 (2003
15. Lang, E. J., Cross, P. J., Mittelstadt, G., Jameson, G. B., & Parker, E. J. Allosteric ACTion: the varied ACT domains regulating enzymes of amino-Acid metabolism. Curr. Opin. Struct. Biol. 29, 102-111 (2014
16. Gjetting, T., Petersen, M., Guldberg, P., & Guttler, F. Missense mutations in the N-Terminal domain of human phenylalanine hydroxylase interfere with binding of regulatory phenylalanine. Am. J. Hum. Genet. 68, 1353-1360 (2001
17. Li, J., Ilangovan, U., Daubner, S. C., Hinck, A. P., & Fitzpatrick, P. F. Direct evidence for a phenylalanine site in the regulatory domain of phenylalanine hydroxylase. Arch. Biochem. Biophys. 505, 250-255 (2011
18. Zhang, S., Roberts, K. M., & Fitzpatrick, P. F. Phenylalanine binding is linked to dimerization of the regulatory domain of phenylalanine hydroxylase. Biochemistry. 53, 6625-6627 (2014
19. Roberts, K. M., Khan, C. A., Hinck, C. S., & Fitzpatrick, P. F. Activation of phenylalanine hydroxylase by phenylalanine does not require binding in the active site. Biochemistry. 53, 7846-7853 (2014
20. Andersen, O. A., Stokka, A. J., Flatmark, T., & Hough, E. 2.0A resolution crystal structures of the ternary complexes of human phenylalanine hydroxylase catalytic domain with tetrahydrobiopterin and 3-(2-Thienyl)-L-Alanine or L-norleucine: substrate specificity and molecular motions related to substrate binding. J. Mol. Biol. 333, 747-757 (2003
21. Wernimont, A., & Edwards, A. In situ proteolysis to generate crystals for structure determination: an update. Plos One. 4, e5094 (2009
22. Kaplun, A., et al. Structure of the regulatory subunit of acetohydroxyacid synthase isozyme III from Escherichia coli. J. Mol. Biol. 357, 951-963 (2006
23. Zhang, S., Huang, T., Ilangovan, U., Hinck, A. P., & Fitzpatrick, P. F. The solution structure of the regulatory domain of tyrosine hydroxylase. J. Mol. Biol. 426, 1483-1497 (2014
24. Zhang, S., & Fitzpatrick, P. F. Identification of the Allosteric Site for Phenylalanine in Rat Phenylalanine Hydroxylase. J. Biol. Chem. doi: 10.1074/jbc.M115.709998 (2016
25. Schuller, D. J., Grant, G. A., & Banaszak, L. J. The allosteric ligand site in the Vmax-Type cooperative enzyme phosphoglycerate dehydrogenase. Nat. Struct. Biol. 2, 69-76 (1995
26. Cross, P. J., Dobson, R. C., Patchett, M. L., & Parker, E. J. Tyrosine latching of a regulatory gate affords allosteric control of aromatic amino acid biosynthesis. J. Biol. Chem. 286, 10216-10224 (2011
27. Gersting, S. W., et al. Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Am. J. Hum. Genet. 83, 5-17 (2008
28. Jaffe, E. K., Stith, L., Lawrence, S. H., Andrake, M., & Dunbrack, R. L. Jr A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics. Arch. Biochem. Biophys. 530, 73-82 (2013
29. Cross, P. J., Allison, T. M., Dobson, R. C., Jameson, G. B., & Parker, E. J. Engineering allosteric control to an unregulated enzyme by transfer of a regulatory domain. Proc. Natl. Acad. Sci. USA. 110, 2111-2116 (2013
30. Phillips, R. S., Iwaki, M., & Kaufman, S. Ligand effects on the limited proteolysis of phenylalanine hydroxylase: evidence for multiple conformational states. Biochem. Biophys. Res. Commun. 110, 919-925 (1983
31. Li, J., Dangott, L. J., & Fitzpatrick, P. F. Regulation of phenylalanine hydroxylase: conformational changes upon phenylalanine binding detected by hydrogen/deuterium exchange and mass spectrometry. Biochemistry. 49, 3327-3335 (2010
32. Kappock, T. J., Harkins, P. C., Friedenberg, S., & Caradonna, J. P. Spectroscopic and kinetic properties of unphosphorylated rat hepatic phenylalanine hydroxylase expressed in Escherichia coli. Comparison of resting and activated states. J. Biol. Chem. 270, 30532-30544 (1995
33. Martinez, A., et al. Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-Type enzyme. Biochem. J. 306 (Pt 2), 589-597 (1995
34. Muntau, A. C., & Gersting, S. W. Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism. J. Inherit. Metab. Dis. 33, 649-658 (2010
35. Underhaug, J., Aubi, O., & Martinez, A. Phenylalanine hydroxylase misfolding and pharmacological chaperones. Curr. Top. Med. Chem. 12, 2534-2545 (2012
36. Leandro, J., Simonsen, N., Saraste, J., Leandro, P., & Flatmark, T. Phenylketonuria as a protein misfolding disease: The mutation pG46S in phenylalanine hydroxylase promotes self-Association and fibril formation. Biochim. Biophys. Acta. 1812, 106-120 (2011
37. Leandro, J., Saraste, J., Leandro, P., & Flatmark, T. The G46S-hPAH mutant protein: a model to study the rescue of aggregation-prone PKU mutations by chaperones. Mol. Genet. Metab. 104, Suppl, S40-44 (2011
38. Pey, A. L., Stricher, F., Serrano, L., & Martinez, A. Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases. Am. J. Hum. Genet. 81, 1006-1024 (2007
39. Erlandsen, H., et al. Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations. Proc. Natl. Acad. Sci. USA. 101, 16903-16908 (2004
40. Muntau, A. C., Leandro, J., Staudigl, M., Mayer, F., & Gersting, S. W. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators. J. Inherit. Metab. Dis. 37, 505-523 (2014
41. Montalbano, F., et al. Phenylalanine iminoboronates as new phenylalanine hydroxylase modulators. RSC Adv. 4, 61022-61027 (2014
42. McCorvie, T. J., et al. Inter-domain communication of human cystathionine beta-synthase: structural basis of S-Adenosyl-Lmethionine activation. J. Biol. Chem. 289, 36018-36030 (2014
43. Jaffe, E. K., & Lawrence, S. H. Allostery and the dynamic oligomerization of porphobilinogen synthase. Arch. Biochem. Biophys. 519, 144-153 (2012
44. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760-763 (1994
45. McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C., & Read, R. J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61, 458-464 (2005
46. Emsley, P., & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004
47. Adams, P. D., et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010
48. Niesen, F. H., Berglund, H., & Vedadi, M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat. Protoc. 2, 2212-2221 (2007
49. Petoukhov, M. V., et al. New developments in the program package for small-Angle scattering data analysis. J. Appl. Crystallogr. 45, 342-350 (2012